Is Elanco Animal Health (ELAN) overvalued? · rev $4.44B
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether Elanco Animal Health (ELAN) looks expensive on cached numbers — not a short thesis.
Latest reported ELAN revenue for 2024-12-31 was $4.44B. Net income was $338.0M. Revenue was up 0.5% from 2023-12-31 to 2024-12-31. ELAN currently screens at market cap $11.80B.
ELAN currently screens at market cap $11.80B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ELAN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ELAN stock page for the full model, not this heading.
Not investment advice.